Investigation on the effects of the atmospheric pressure plasma on wound healing in diabetic rats

• Published in: Scientific reports Vol. 6; no. 1; p. 19144
• Main Authors: Fathollah, Sara, Mirpour, Shahriar, Mansouri, Parvin, Dehpour, Ahmad Reza, Ghoranneviss, Mahmood, Rahimi, Nastaran, Safaie Naraghi, Zahra, Chalangari, Reza, Chalangari, Katalin Martits
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 23.02.2016
• Subjects: Animals; Atmospheric pressure; Biomarkers - metabolism; Cell proliferation; Collagen - genetics; Collagen - metabolism; Contraction; Cytokines; Diabetes; Diabetes mellitus; Diabetes Mellitus, Experimental - chemically induced; Diabetes Mellitus, Experimental - metabolism; Diabetes Mellitus, Experimental - pathology; Epidermis; Gene Expression; Helium; Helium - pharmacology; Immunohistochemistry; Male; Neovascularization, Physiologic - drug effects; Plasma; Plasma Gases - pharmacology; Rats; Rodents; Skin - drug effects; Skin - metabolism; Skin - pathology; Streptozocin; Transforming growth factor; Transforming Growth Factor beta1 - genetics; Transforming Growth Factor beta1 - metabolism; Transforming growth factor-b1; Ulcers; Vascularization; Wound healing; Wound Healing - drug effects; Wounds, Nonpenetrating - metabolism; Wounds, Nonpenetrating - pathology; Wounds, Nonpenetrating - therapy
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/srep19144

It is estimated that 15 percent of individuals with diabetes mellitus suffer from diabetic ulcers worldwide. The aim of this study is to present a non-thermal atmospheric plasma treatment as a novel therapy for diabetic wounds. The plasma consists of ionized helium gas that is produced by a high-voltage (8 kV) and high-frequency (6 kHz) power supply. Diabetes was induced in rats via an intravascular injection of streptozotocin. The plasma was then introduced to artificial xerograph wounds in the rats for 10 minutes. Immunohistochemistry assays was performed to determine the level of transforming growth factor (TGF-β1) cytokine. The results showed a low healing rate in the diabetic wounds compared with the wound-healing rate in non-diabetic animals (P < 0.05). Moreover, the results noted that plasma enhanced the wound-healing rate in the non-diabetic rats (P < 0.05), and significant wound contraction occurred after the plasma treatment compared with untreated diabetic wounds (P < 0.05). Histological analyses revealed the formation of an epidermis layer, neovascularization and cell proliferation. The plasma treatment also resulted in the release of TGF-β1 cytokine from cells in the tissue medium. The findings of this study demonstrate the effect of plasma treatment for wound healing in diabetic rats.